Our Portfolio

Pivotal Scientific are delighted to have advised the shareholders of Absolute Antibody, Ltd. (UK) and its sister company Kerafast on their sale to LSBio (USA). Pivotal Scientific’s CEO, Tim Bernard, has been on the Board of Absolute Antibody since their inception in 2012. Throughout this time Tim has provided commercial and strategic advice, helping to facilitate their continued growth. Absolute Antibody contacted Tim and the team at Pivotal Scientific earlier this year to promote and manage the sale of Absolute Antibody. Tim Bernard commented, ‘it…

Lsbio Abab

Our unique team of consultants offer a wealth of expertise across different fields gained from experience in both the scientific and commercial marketplaces. With an expanding portfolio of successful projects our knowledge base continues to grow along with our confidence to offer the best advice ensuring you achieve the most desirable business outcomes. Below are some of our most recent projects:

Lsbio Everest

LifeSpan BioSciences, Inc. announces the acquisition of Everest Biotech

Release Date: July 31st, 2019 Seattle, Washington State, USA– June 2019 – LifeSpan BioSciences (LSBio), a leading provider of antibodies and life science research reagents…

Read More »

Ecb Medix

Pivotal Scientific advises EastCoast Bio on its sale to Medix Biochemica

A successful transaction benefitting both parties. Pivotal Scientific is delighted to announce its assistance in the sale of US-based biotech firm EastCoast Bio to the…

Read More »


Pivotal Scientific advises Antibody BCN on its sale to CliniSciences

CliniSciences adds to its portfolio of companies Pivotal Scientific Limited (PSL) is pleased to announce its assistance in the sale of Spanish based Biotechnology company AbBcn…

Read More »


Chromocyte Limited

Chromocyte is a free academic driven portal dedicated to flow cytometry and other antibody-related techniques. It was launched in 2010 by Professor Graham Pockley, Director…

Read More »